Keyphrases
MT1-MMP
100%
Matrix Metalloproteinase Activity
71%
MicroRNA
56%
Conserved Non-coding Elements
50%
Epigenetic Modification
50%
Metabolic Cues
50%
Forkhead Box P3 (FOXP3)
50%
Anergy
50%
MiR-335
50%
MiR-182
50%
Cell Surface
50%
Surface Membrane
50%
Surface Expression
50%
Regulatory T (Treg) Cells
50%
Anergic
25%
CD4 T Cells
25%
Anti-miR
21%
BPH-1
20%
HT1080
19%
MiR-183
14%
Trichostatin A
14%
Peripheral Immune Cells
12%
Self-tolerance
12%
Protective Mechanism
12%
Thymus
12%
Autoreactive
12%
Treg Differentiation
12%
Foxp3 Expression
12%
DNA Methylation (DNAm)
12%
FoxP3+
12%
Mechanistic Aspects
12%
Autoreactive T Cells
12%
Regulatory T
12%
Immune Self
12%
Treg
12%
Metabolic Programming
12%
Autoimmunity
12%
Healthy Tissue
12%
Foxp3+ Tregs
12%
Cell Migration
12%
Tumor Cells
12%
Autoreactive Lymphocyte
12%
Phenotypic Characteristics
12%
In Vitro Wound Healing Assay
7%
MiR-96
7%
Pathological Process
7%
Cell Motility
7%
Physiological Processes
7%
Benign Prostatic Hyperplasia
7%
HT-1080 Cells
7%
Medicine and Dentistry
microRNA
50%
T-Helper Cell
50%
microRNA 182
50%
Regulatory T Cell
50%
Cell Surface
50%
Matrix Metalloproteinase 14
50%
Immunity
50%
Autoimmunity
25%
Cell Differentiation
25%
Precursor
25%
Thymus
25%
T Cell
25%
Immunological Tolerance
25%
DNA Methylation
25%
Lymphocyte
25%
Benign Prostatic Hyperplasia
14%
Trichostatin A
14%
Messenger RNA
14%
HT1080
7%
Prostatic Hyperplasia Cell Line
7%
In Vitro
7%
Fibrosarcoma Cell
7%
Wound Healing
7%
Pathological Process
7%
Prostate Hypertrophy
7%
Cell Motility
7%
Cell Migration
7%
Immunology and Microbiology
Cell Surface
100%
Regulatory T Cell
50%
Cell Migration
40%
Tumor Cell
33%
T-Helper Cell
16%
Wound Healing
16%
Cell Proliferation
16%
Cell Membrane
16%
Immunity
16%
Immune Tolerance
8%
Autoimmunity
8%
Thymus
8%
Cell Differentiation
8%
Precursor
8%
DNA Methylation
8%
T Cell
8%
Lymphocyte
8%
Prostatic Hyperplasia Cell Line
7%
Cell Motility
7%
Wound Healing Assay
7%
Fibrosarcoma Cell
7%